Last Price
303.99
Today's Change
+0.89 (0.29%)
Day's Change
300.79 - 305.00
Trading Volume
512,060
Market Cap
147 Billion
Shares Outstanding
484 Million
Avg Volume
687,333
Avg Price (50 Days)
305.09
Avg Price (200 Days)
289.05
PE Ratio
37.44
EPS
8.12
Earnings Announcement
12-Feb-2025
Previous Close
303.10
Open
302.12
Day's Range
300.79 - 305.0
Year Range
228.65 - 313.55
Trading Volume
512,060
1 Day Change
0.29%
5 Day Change
-0.90%
1 Month Change
-0.14%
3 Month Change
5.19%
6 Month Change
7.86%
Ytd Change
5.44%
1 Year Change
13.34%
3 Year Change
-2.02%
5 Year Change
26.90%
10 Year Change
321.27%
Max Change
36658.16%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.